Abstracts

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30 Wed, Oct 01

Sunday, September 28

1:00 PM - 2:30 PM PT

Clinical Trials
Speaker: Rosenzweig, Kenneth, MD, FASTRO - Icahn School of Medicine at Mount Sinai, New York, New York
1:00 PM - 2:30 PM PT

Clinical Trials
Speaker: Siddiqui, Farzan, MD, PhD, FASTRO - Henry Ford Hospital/Wayne State University, Detroit, MI
1:00 PM - 1:10 PM PT

LBA 04 - A Double-Blinded Placebo-Controlled Biomarker Stratified Randomized Trial of Apalutamide (APA) and Radiotherapy for Recurrent Prostate Cancer (NRG GU006, BALANCE trial)
Speaker: Spratt, Daniel, MD - University Hospitals Seidman Cancer Center, Case Western Reserve University, Beachwood, OH
1:10 PM - 1:20 PM PT

3 - 177 Lutetium-PSMA Neoadjuvant to Ablative Radiotherapy for Oligorecurrent Prostate Cancer; Primary Endpoint Analysis of the Phase II LUNAR Randomized Trial
Speaker: Kishan, Amar, MD, PhD - UCLA, Culver City, California
1:20 PM - 1:30 PM PT

LBA 05 - Androgen Deprivation Therapy (ADT) and High Dose Definitive Radiotherapy (RT) +/- Whole Pelvic RT in Patients with Unfavorable Intermediate or Favorable High-Risk Prostate Cancer: Early Results of a Phase III Randomized Controlled Trial
Speaker: Roach, Mack, MD, PhD, FASTRO - University of California San Francisco, San Francisco, CA
1:30 PM - 1:40 PM PT

248 - Toxicities and Quality of Life Following Observation or Radiation Therapy for Dupuytren's Disease in the International DEPART Randomized Trial
Speaker: Martin, Jarad, MD, MB, ChB, PhD, BSc FRANZCR GAustMS - Calvary Mater Newcastle Hospital, Newcastle, NSW
1:40 PM - 1:50 PM PT

LBA 06 - Clinical Effectiveness of Single Course Low-Dose Radiation Therapy in Knee Osteoarthritis: Short-term Results from the Randomized, Sham-Controlled Trial
Speaker: Kim, Byoung Hyuck, MD, PhD - SMG-SNU Boramae Medical Center, Seoul, BUS
1:50 PM - 2:00 PM PT

4 - Decreasing the Dose of Consolidation Radiation Therapy in DLBCL/HGBL: A Phase II Trial by the International Lymphoma Radiation Oncology Group
Speaker: Kelsey, Christopher, MD, FASTRO - Duke University Medical Center, Durham, North Carolina
2:00 PM - 2:10 PM PT

LBA 07 - Efficacy of Hypofractionated Stereotactic Radiotherapy with Different Dose Fractionation Regimens Combined with Concurrent Bevacizumab in Recurrent High-Grade Gliomas: A Randomized Controlled Trial
Speaker: Liu, Feng, MD - Hunan Cancer Hospital, Changsha, Hunan
2:30 PM - 2:40 PM PT

100 - Multicenter, Phase 3 Randomized Trial of Stereotactic Radiation vs. Hippocampal Avoidance Whole Brain Radiation in Patients with 5-20 Brain Metastases: Recurrence, Salvage Therapy, and Mortality Endpoints
Speaker: Aizer, Ayal, MD - Brigham and Women's Hospital, Boston, MA
2:30 PM - 2:40 PM PT

107 - Quality of Life and 5-Year Long-Term Organ Preservation in Early Rectal Adenocarcinoma Final Results from the OPERA Trial
Speaker: ben Dhia, Syrine, MD - Antoine lacassagne center, nice
2:30 PM - 2:40 PM PT

114 - Phase 3, Randomized, Placebo Controlled Clinical Trial of CAN-2409+Prodrug in Combination with Standard of Care External Beam Radiation (EBRT) for Newly Diagnosed Localized Prostate Cancer
Speaker: Gejerman, Glen, MD, MBA - Hackensack University Medical Center, Hackensack, NJ